aclens.com - Acuvue Contact Lenses for Less    Shop Warby Parker Online   



Planned Spin-Off Will Allow Alcon to Better Focus on Growth Strategies, CEO Endicott Says

FORT WORTH, Texas—The “new” Alcon that emerges from a planned spin-off from Novartis (NYSE: NVS) in the first half of 2019 will look much like “a $7 billion start-up” with a rapt focus on innovation and R&D as it attempts to address ongoing changes in the delivery of eyecare, chief executive officer David Endicott said this week at the company’s Innovation for Better Vision session....


J&J Cites Pharmaceutical Segment for Driving a 10.6 Percent Increase in Second-Quarter Sales

NEW BRUNSWICK, N.J.—Johnson & Johnson (NYSE: JNJ) on Tuesday reported that its sales rose 10.6 percent to $20.8 billion in the second quarter, due in part to a 19.9 percent sales increase in its pharmaceutical business segment. On an operational basis, the company’s overall sales increase was 8.7 percent, and the positive impact of currency was 1.9 percent, according to the announcement. Domestic sales increased 9.4 percent, while international sales rose 11.8 percent, reflecting operational gro...


Alcon’s New CEO Endicott Says Eyecare Company Is Committed to Fort Worth

FORT WORTH, Texas—Alcon expects to build upon its 70 years of history in this Texas metro area following its spinoff from parent company Novartis in 2019, the eyecare group’s new chief executive officer has said. “Fort Worth is where Alcon was born more than 70 years ago, and we look forward to building on our legacy here following the proposed spinoff,” chief executive officer David Endicott said in a statement to the Star-Telegram of Fort Worth earlier this week....


SynergEyes Appoints Bob Ferrigno as CEO; Prepares to Boost Specialty Business

CARLSBAD, Calif.—The board of directors of SynergEyes, Inc. has appointed Bob Ferrigno as chief executive officer, effective June 27....


Bausch + Lomb Announces Licensing Agreement With Tangible Science for Use of Custom Contact Lens Coating Technology

BRIDGEWATER, N.J.—Bausch + Lomb, a leading global eye health company, announced that it has entered into a worldwide licensing agreement with Tangible Science, LLC, a company whose mission is to create technologies that improve the contact lens wearing experience....


SynergEyes and Brien Holden Vision Institute Partner on Contact Lens Development

CARLSBAD, Calif.—SynergEyes, a leading hybrid specialty contact lens company, announced a new partnership with the Brien Holden Vision Institute,  the leading translational vision correction center which delivers advanced, customized vision correction for myopes and presbyopes. The exclusive worldwide licensing agreement will enable the manufacturing of design technologies developed by Brien Holden Vision Institute, augmenting the SynergEyes presbyopic package by offering the latest designs on t...


Contact Lenses News:

Planned Spin-Off Will Allow Alcon to Better Focus on Growth Strategies, CEO Endicott Says

FORT WORTH, Texas—The “new” Alcon that emerges from a planned spin-off from Novartis (NYSE: NVS) in the first half of 2019 will look much like “a $7 billion start-up” with a rapt focus on innovation and R&D as it attempts to address ongoing changes in the delivery of eyecare, chief executive officer David Endicott said this week at the company’s Innovation for Better Vision session....


J&J Cites Pharmaceutical Segment for Driving a 10.6 Percent Increase in Second-Quarter Sales

NEW BRUNSWICK, N.J.—Johnson & Johnson (NYSE: JNJ) on Tuesday reported that its sales rose 10.6 percent to $20.8 billion in the second quarter, due in part to a 19.9 percent sales increase in its pharmaceutical business segment. On an operational basis, the company’s overall sales increase was 8.7 percent, and the positive impact of currency was 1.9 percent, according to the announcement. Domestic sales increased 9.4 percent, while international sales rose 11.8 percent, reflecting operational gro...


Alcon’s New CEO Endicott Says Eyecare Company Is Committed to Fort Worth

FORT WORTH, Texas—Alcon expects to build upon its 70 years of history in this Texas metro area following its spinoff from parent company Novartis in 2019, the eyecare group’s new chief executive officer has said. “Fort Worth is where Alcon was born more than 70 years ago, and we look forward to building on our legacy here following the proposed spinoff,” chief executive officer David Endicott said in a statement to the Star-Telegram of Fort Worth earlier this week....


SynergEyes Appoints Bob Ferrigno as CEO; Prepares to Boost Specialty Business

CARLSBAD, Calif.—The board of directors of SynergEyes, Inc. has appointed Bob Ferrigno as chief executive officer, effective June 27....


Bausch + Lomb Announces Licensing Agreement With Tangible Science for Use of Custom Contact Lens Coating Technology

BRIDGEWATER, N.J.—Bausch + Lomb, a leading global eye health company, announced that it has entered into a worldwide licensing agreement with Tangible Science, LLC, a company whose mission is to create technologies that improve the contact lens wearing experience....


SynergEyes and Brien Holden Vision Institute Partner on Contact Lens Development

CARLSBAD, Calif.—SynergEyes, a leading hybrid specialty contact lens company, announced a new partnership with the Brien Holden Vision Institute,  the leading translational vision correction center which delivers advanced, customized vision correction for myopes and presbyopes. The exclusive worldwide licensing agreement will enable the manufacturing of design technologies developed by Brien Holden Vision Institute, augmenting the SynergEyes presbyopic package by offering the latest designs on t...


SKU-J21-57125 1-Day Acuvue Define 30PK from 1 800 get lens  sku

1-Day Acuvue Define 30PK - J21-57125 by Johnson & Johnson

Item description: This Contact Lenses Daily Disposable product is by Johnson & Johnson - Introducing the new 1-Day Acuvue Define brand contact lenses, a new category of prescription eye enhancement lenses that accentuate the eye's natural beauty. Our innovative new contact lenses enhance the natural beauty of the eye, adding natural-looking definition to the limbal ring. Made with Lacreon technology, 1-Day Acuvue Define contacts offer great lens performance, the convenience and health of a daily disposable, and comes in five options to blend with all eye colors: Natural Sparkle, Natural Shimmer, Natural Shine, Accent Style, and Vivid Style.... Learn More

Manufacturer: Johnson & Johnson

Keywords: 1-Day Acuvue Define 30PK Johnson & Johnson Daily Disposable

1-800-GET-LENS

Store: We provide customers with top brands like Bausch&Lomb and Johnson&Johnson - brands that customers know and trust.

Category: Daily Disposable

$40.00

See the Price of 1-Day Acuvue Define 30PK

You may also consider:

  1-Day Acuvue Define 90PK
Introducing the new 1-Day Acuvue Define brand contact lenses, a new category of prescription eye enhancement lenses that accentuate the eye's natural beauty. Our innovative new contact lenses enhance the natural beauty of the eye, adding natural-looking definition to the limbal ring. Made with Lacreon technology, 1-Day Acuvue Define contacts offer great lens performance, the convenience and health of a daily disposable, and comes in five options to blend with all eye colors: Natural Sparkle, Nat ...See The Price
 
  1-Day Acuvue Moist Multifocal 90PK
Introducing the new 1-DAY ACUVUE-« MOIST Brand MULTIFOCAL. The only multifocal lenses specifically designed to match the aspheric center-near optical design to the pupil size as it changes across the refractive range and as patients age. Precise and consistent centration allows for a superior vision experience. ...See The Price
 
  1-Day Acuvue Moist for Astigmatism 90PK
Along with the convenience of no solutions and no lens cases, Acuvue has brough together their innovative BLINK STABILIZED lens design and the exceptional comfort of LACREON-« Technology to form a lens like no other. It gives you consistently clear and comfortable vision from the moment you put them in, to the moment you toss them at the end of the day. ...See The Price